Hyaluronan (HA) Interacting Proteins RHAMM and Hyaluronidase Impact Prostate Cancer Cell Behavior and Invadopodia Formation in 3D HA-Based Hydrogels

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Gurski, Lisa A ^a   Xu, Xian ^a   Labrada, Lyana N ^a   Nguyen, Ngoc T ^a   Xiao, Longxi ^a   van Golen, Kenneth L ^a   Jia, Xinqiao ^a   Farach Carson, Mary C ^a,b,c  

^a UNIVERSITY OF DELAWARE   (United States)

^b RICE UNIVERSITY   (United States)

^c Rice University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; HYALURONIC ACID BINDING PROTEIN; HYALURONIDASE; RECEPTOR FOR HYALURONAN MEDIATED MOTILITY; UNCLASSIFIED DRUG;

ARTICLE; BIOTINYLATION; BONE MARROW; CANCER CELL; CELL ENCAPSULATION; CELL FUNCTION; CELL INVASION; CELL MOTILITY; CELL STRUCTURE; CELL SURFACE; CONNECTIVE TISSUE; CONTROLLED STUDY; CROSS LINKING; ENZYME ACTIVITY; ENZYME INHIBITION; FLOW KINETICS; HUMAN; HUMAN CELL; HYDROGEL; IMMUNOHISTOCHEMISTRY; INVADOPODIA; PROSTATE CANCER; PROTEIN FUNCTION; WESTERN BLOTTING;

ANTIGENS, CD44; BIOTINYLATION; BLOTTING, WESTERN; CELL MIGRATION ASSAYS; CELL SURFACE EXTENSIONS; EXTRACELLULAR MATRIX PROTEINS; GENE KNOCKDOWN TECHNIQUES; HUMANS; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; HYDROGELS; MALE; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; RHEOLOGY; TRYPAN BLUE; TUMOR CELLS, CULTURED;

EID: 84869208688     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050075     Document Type: Article

References (54)

1. Society AC (2012) Cancer Facts and Figures 2012.
2. Coleman RE, (2012) Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity. Clinical Cancer Research 12: 6243s-6249s.
3. Decaestecker C, Debeir O, Van Ham P, Kiss R, (2007) Can anti-migratory drugs be screened in vitro? A review of 2D and 3D assays for the quantitative analysis of cell migration. Medicinal Research Reviews 27: 149-176.
4. Yamaguchi H, Wyckoff J, Condeelis J, (2005) Cell migration in tumors. Current Opinion in Cell Biology 17: 559-564.
5. Marshall J, (2011) Transwell() invasion assays. Methods in molecular biology (Clifton, NJ) 769: 97-110.
6. van Horssen R, ten Hagen TLM, (2011) Crossing Barriers: The New Dimension of 2D Cell Migration Assays. Journal of Cellular Physiology 226: 288-290.
7. Clark BR, Keating A, (1995) Biology of bone marrow stroma. Bone Marrow Transplantation: Foundations for the 21st Century 770: 70-78.
8. Schade UM, Nehmann N, Horny HP, Prehm P, Delpech B, et al. (2006) Hyaluronate and its receptors in bone marrow. Acta Histochemica 108: 141-147.
9. Meyer K, (1958) CHEMICAL STRUCTURE OF HYALURONIC ACID. Federation Proceedings 17: 1075-1077.
10. Stern R, (2008) Hyaluronidases in cancer biology. Seminars in Cancer Biology 18: 275-280.
11. Hamilton SR, Fard SF, Paiwand FF, Tolg C, Veiseh M, et al. (2007) The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells. Journal of Biological Chemistry 282: 16667-16680.
12. Turley EA, Austen L, Vandeligt K, Clary C, (1991) HYALURONAN AND A CELL-ASSOCIATED HYALURONAN BINDING-PROTEIN REGULATE THE LOCOMOTION OF RAS-TRANSFORMED CELLS. Journal of Cell Biology 112: 1041-1047.
13. Ekici S, Cerwinka WH, Duncan R, Gomez P, Civantos F, et al. (2004) Comparison of the prognostic potential of hyaluronic acid, hyaluronidase (HYAL-1), CD44v6 and microvessel density for prostate cancer. International Journal of Cancer 112: 121-129.
14. Gust KM, Hofer MD, Perner SR, Kim R, Chinnaiyan AM, et al. (2009) RHAMM (CD168) Is Overexpressed at the Protein Level and May Constitute an Immunogenic Antigen in Advanced Prostate Cancer Disease. Neoplasia 11: 956-963.
15. Bharadwaj AG, Kovar JL, Loughman E, Elowsky C, Oakley GG, et al. (2009) Spontaneous Metastasis of Prostate Cancer Is Promoted by Excess Hyaluronan Synthesis and Processing. American Journal of Pathology 174: 1027-1036.
16. Gomez CS, Gomez P, Knapp J, Jorda M, Soloway MS, et al. (2009) Hyaluronic Acid and HYAL-1 in Prostate Biopsy Specimens: Predictors of Biochemical Recurrence. Journal of Urology 182: 1350-1355.
17. Hofinger ESA, Hoechstetter J, Oettl M, Bernhardt G, Buschauer A, (2008) Isoenzyme-specific differences in the degradation of hyaluronic acid by mammalian-type hyaluronidases. Glycoconjugate Journal 25: 101-109.
18. Harada H, Takahashi M, (2007) CD44-dependent intracellular and extracellular catabolism of hyaluronic acid by hyaluronidase-1 and-2. Journal of Biological Chemistry 282: 5597-5607.
19. Csoka AB, Frost GI, Stern R, (2001) The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biology 20: 499-508.
20. Huxley-Jones J, Foord SM, Barnes MR, (2008) Drug discovery in the extracellular matrix. Drug Discovery Today 13: 685-694.
21. Russ AP, Lampel S, (2005) The druggable genome: an update. Drug Discovery Today 10: 1607-1610.
22. Kakegawa H, Matsumoto H, Satoh T, (1985) ACTIVATION OF HYALURONIDASE BY METALLIC SALTS AND COMPOUND 48/80, AND INHIBITORY EFFECT OF ANTI-ALLERGIC AGENTS ON HYALURONIDASE. Chemical & Pharmaceutical Bulletin 33: 642-646.
23. Mio K, Stern R, (2002) Inhibitors of the hyaluronidases. Matrix Biology 21: 31-37.
24. Chen JL, Moore N, Norman PS, Vanmetre TE (1969) DISODIUM CROMOGLYCATE A NEW COMPOUND FOR PREVENTION OF EXACERBATIONS OF ASTHMA. Journal of Allergy 43: 89-&.
25. Edwards AM, Howell JBL, (2000) The chromones: history, chemistry and clinical development. A tribute to the work of Dr R. E. C. Altounyan. Clinical and Experimental Allergy 30: 756-774.
26. Gurski LA, Jha AK, Zhang C, Jia XQ, Farach-Carson MC, (2009) Hyaluronic acid-based hydrogels as 3D matrices for in vitro evaluation of chemotherapeutic drugs using poorly adherent prostate cancer cells. Biomaterials 30: 6076-6085.
27. Jia XQ, Colombo G, Padera R, Langer R, Kohane DS, (2004) Prolongation of sciatic nerve blockade by in situ cross-linked hyaluronic acid. Biomaterials 25: 4797-4804.
28. Wu TT, Sikes RA, Cui QJ, Thalmann GN, Kao CH, et al. (1998) Establishing human prostate cancer cell xenografts in bone: Induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines. International Journal of Cancer 77: 887-894.
29. Thalmann GN, Sikes RA, Wu TT, Degeorges A, Chang SM, et al. (2000) LNCaP progression model of human prostate cancer: Androgen-independence and osseous metastasis. Prostate 44: 91-103.
30. Thalmann GN, Anezinis PE, Chang SM, Zhau HE, Kim EE, et al. (1994) ANDROGEN-INDEPENDENT CANCER PROGRESSION AND BONE METASTASIS IN THE LNCAP MODEL OF HUMAN PROSTATE-CANCER. Cancer Research 54: 2577-2581.
31. He XY, Sikes RA, Thomsen S, Chung LWK, Jacques SL, (1994) PHOTODYNAMIC THERAPY WITH PHOTOFRIN-II INDUCES PROGRAMMED CELL-DEATH IN CARCINOMA CELL-LINES. Photochemistry and Photobiology 59: 468-473.
32. Thalmann GN, Sikes RA, Devoll RE, Kiefer JA, Markwalder R, et al. (1999) Osteopontin: Possible role in prostate cancer progression. Clinical Cancer Research 5: 2271-2277.
33. Zhang C, Soori M, Miles FL, Sikes RA, Carson DD, et al. (2011) Paracrine Factors Produced by Bone Marrow Stromal Cells Induce Apoptosis and Neuroendocrine Differentiation in Prostate Cancer Cells. Prostate 71: 157-167.
34. Sahiner N, Jha AK, Nguyen D, Jia XQ, (2008) Fabrication and characterization of cross-linkable hydrogel particles based on hyaluronic acid: potential application in vocal fold regeneration. Journal of Biomaterials Science-Polymer Edition 19: 223-243.
35. Guntenhoner MW, Pogrel MA, Stern R, (1992) A SUBSTRATE-GEL ASSAY FOR HYALURONIDASE ACTIVITY. Matrix 12: 388-396.
36. Miura RO, Yamagata S, Miura Y, Harada T, Yamagata T, (1995) ANALYSIS OF GLYCOSAMINOGLYCAN-DEGRADING ENZYMES BY SUBSTRATE GEL-ELECTROPHORESIS (ZYMOGRAPHY). Analytical Biochemistry 225: 333-340.
37. Barla F, Higashijima H, Funai S, Sugimoto K, Harada N, et al. (2009) Inhibitive Effects of Alkyl Gallates on Hyaluronidase and Collagenase. Bioscience Biotechnology and Biochemistry 73: 2335-2337.
38. Shaw MT, MacKnight WJ (2005) Introduction to Polymer Viscoelasticity. Hoboken, NJ: John Wiley & Sons, Inc.
39. Harrison GM, Davies G, Martin TA, Mason MD, Jiang WG, (2006) The influence of CD44v3-v10 on adhesion, invasion and MMP-14 expression in prostate cancer cells. Oncology Reports 15: 199-206.
40. Ricciardelli C, Russell DL, Ween MP, Mayne K, Suwiwat S, et al. (2007) Formation of hyaluronan- and versican-rich pericellular matrix by prostate cancer cells promotes cell motility. Journal of Biological Chemistry 282: 10814-10825.
41. Hurt EM, Kawasaki BT, Klarmann GJ, Thomas SB, Farrar WL, (2008) CD44(+)CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis. British Journal of Cancer 98: 756-765.
42. Xiao WW, Graham PH, Power CA, Hao JL, Kearsley JH, et al. (2012) CD44 is a biomarker associated with human prostate cancer radiation sensitivity. Clinical & Experimental Metastasis 29: 1-9.
43. Goueffic Y, Guilluy C, Guerin P, Patra P, Pacaud P, et al. (2006) Hyaluronan induces vascular smooth muscle cell migration through RHAMM-mediated PI3K-dependent Rac activation. Cardiovascular Research 72: 339-348.
44. Zhang SW, Chang MCY, Zylka D, Turley S, Harrison R, et al. (1998) The hyaluronan receptor RHAMM regulates extracellular-regulated kinase. Journal of Biological Chemistry 273: 11342-11348.
45. Reiman T, Maxwell CA, Adamia S, Belch AR, Pilarski LM, (2003) A RHAMM splice variant correlates with significantly reduced survival and heralds relapse in multiple myeloma. Blood 102: 680A-680A.
46. Maxwell CA, McCarthy J, Turley E, (2008) Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions? Journal of Cell Science 121: 925-932.
47. Lokeshwar VB, Lokeshwar BL, Pham HT, Block NL, (1996) Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression. Cancer Research 56: 651-657.
48. Murphy DA, Courtneidge SA, (2011) The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function. Nature Reviews Molecular Cell Biology 12: 413-426.
49. Harper K, Arsenault D, Boulay-Jean S, Lauzier A, Lucien F, et al. (2010) Autotaxin Promotes Cancer Invasion via the Lysophosphatidic Acid Receptor 4: Participation of the Cyclic AMP/EPAC/Rac1 Signaling Pathway in Invadopodia Formation. Cancer Research 70: 4634-4643.
50. Busco G, Cardone RA, Greco MR, Bellizzi A, Colella M, et al. (2010) NHE1 promotes invadopodial ECM proteolysis through acidification of the peri-invadopodial space. Faseb Journal 24: 3903-3915.
51. Bourguignon LYW, Singleton PA, Diedrich F, Stern R, Gilad E, (2004) CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion. Journal of Biological Chemistry 279: 26991-27007.
52. Kobayashi T, Inoue T, Shimizu Y, Terada N, Maeno A, et al. (2010) Activation of Rac1 Is Closely Related to Androgen-Independent Cell Proliferation of Prostate Cancer Cells Both in Vitro and in Vivo. Molecular Endocrinology 24: 722-734.
53. Sequeira L, Dubyk CW, Riesenberger TA, Cooper CR, van Golen KL, (2008) Rho GTPases in PC-3 prostate cancer cell morphology, invasion and tumor cell diapedesis. Clinical & Experimental Metastasis 25: 569-579.
54. Lokeshwar VB, Rubinowicz D, Schroeder GL, Forgacs E, Minna JD, et al. (2001) Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer. Journal of Biological Chemistry 276: 11922-11932.